Meet Thoracic Surgeon Daniela Molena
Meet Thoracic Surgeon Daniela Molena
Daniela Molena, MD
Thoracic Surgeon
Titles
Director, Esophageal Surgery Program
Clinical Expertise
Esophageal Cancer; Lung Cancer; Thymic Malignancies; Pulmonary Metastases; Mesothelioma; Paraesophageal Hernias; GERD; Barrett’s Esophagus; Bronchoscopy and Endobronchial Ultrasound; Gastrointestinal Endoscopy; Minimally Invasive Surgery
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Molena accepts the following list of insurance providers. Select your insurance provider to see more details.
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO, DSN
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO EPO
Payor Type: Commercial
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): Federal Government
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP
Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): TBD
Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO
Payor Type: Commercial
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Contact and Location
- 212-639-3870 Office Phone
- Speaks English and Italian
- New York City
- Memorial Sloan Kettering Monmouth Middletown, NJ

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
See all locationsAbout Me
Education
MD, University of Padova School of Medicine
Residencies
General Surgery - University of Padova; General Surgery - University of Rochester Medical Center
Fellowships
Gastrointestinal Surgery - University of California San Francisco; Minimally Invasive Surgery - University of Padova; Cardiothoracic Surgery - NewYork Presbyerian/Weill Cornell Medical Center; Cardiothoracic Surgery - University of Pittsburgh Medical Center; Cardiothoracic Surgery - Memorial Sloan Kettering Cancer Center
Board Certifications
Thoracic Surgery; General Surgery
I am an experienced thoracic surgeon with expertise in diagnosing and treating people with cancers of the chest, including the lungs, esophagus, mediastinum, and pleura. I also have a deep understanding of benign esophageal diseases (such as GERD, Barrett’s esophagus, hiatal hernia, and other potential precursors of esophageal cancer) and dysmotility disorders (such as achalasia, diverticula, and ineffective motility), which can severely impair quality of life in people with cancer.
Read more
I perform about 500 operations each year and care for approximately 1,500 patients annually. Whenever possible, I use minimally invasive techniques such as video-assisted thoracic surgery and laparoscopic or robotic procedures to decrease pain and enhance recovery.
I strive to provide excellent and individualized care to my patients. As a strong patient advocate, I try to involve both patients and caregivers and work with them as a team from diagnosis to recovery and follow-up.
A cancer diagnosis is a very stressful event for patients and their loved ones. Patients often fear for their lives and worry about burdening their family members. I feel honored that patients trust me during such a challenging time to help them with decisions that are difficult and complex. I always reassure my patients that we are in this fight together and I hope they feel encouraged, understood, and confident that they have me as an ally along the way.
Every patient is unique and I work with experts from multiple disciplines to develop the best treatment plan that is tailored to their specific needs. It’s fulfilling to see patients go back to their lives, cancer-free. I also thrive on the complexity of thoracic oncology and the opportunities I have to move the field forward.
As Director of Memorial Sloan Kettering’s Esophageal Program, I lead a supportive team that helps people with esophageal cancer understand what to expect during their journey, prepares them for surgery, and helps them recover as quickly as possible. I also developed MSK’s Barrett’s program in collaboration with my colleagues in gastroenterology to identify people who are at risk of developing esophageal cancer and help prevent progression.
I study and integrate new technology and novel surgical approaches to make surgery more precise and effective. For example, for people early stage disease, we are able to save the esophagus and remove the cancer using an endoscope through the mouth. We can also remove and reconstruct the esophagus using small incisions and a camera either with minimally invasive or robotic approaches. For those who have more advanced cancer, we offer personalized treatments that are based on the patient’s specific genomic analysis.
My research focuses on zeroing in on ways to improve clinical and functional outcomes after surgery, designing clinical pathways to decrease costs and improve results, and identifying racial and socioeconomic disparities that limit access to excellent care.
I co-lead several clinical trials that are investigating the role of immunotherapy and/or targeted therapy before or after surgery in patients with esophageal cancer. I am also Principal Investigator of a trial that aims to identify sentinel nodes in esophageal cancer in order to limit surgical dissection in the future.
I am the vice president of Women in Thoracic Surgery and have a leadership role of several thoracic organizations in the US and abroad. I am also editor and associate editor of national and international thoracic journals.
Outside of work, I love to travel and go on family vacations with my husband, son, and daughter. I look forward to visiting my family back in Italy and hiking in the Dolomite Mountains there, which holds a very special place in my heart. We also like to sail on the Long Island Sound and have chartered boats in the Caribbean.
I have a green thumb and my home is filled with many plants. It gives me great pleasure to see plants grow. Every new leaf is a celebration. I especially enjoy rescuing orchids, which my husband sometimes finds in the trash and carries them home for me to bring back to life! I re-pot them and fix their roots and when they flower their beauty brightens my day and makes me happy!
My dog Spritz also brings me joy. We adopted our adorable, 90-pound chocolate mud from a shelter. He looks like a chocolate lab but has seven different breeds in him (I checked his DNA!) He is my baby now that our kids have left the house and we are empty nesters!
Awards and Honors
- America’s Top Doctors (2017-2023)
- Castle Connolly: New York Magazine Top Doctors (2017-2021)
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Co-Investigated by Dr. Molena
- A Phase I Study of Telomelysin Added to Chemoradiation for Patients with Advanced Inoperable Esophageal Cancer
- A Phase I/II Study of Durvalumab and Chemoradiation before Surgery for Esophageal Cancer

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Nobel TB, Livschitz J, Eljalby M, Janjigian YY, Bains MS, Adusumilli PS, Jones DR, Molena D. Unique Considerations for Females Undergoing Esophagectomy. Ann Surg. 2020 Jul;272(1):113-117. doi: 10.1097/SLA.0000000000003202.
Molena D, DeMeester SR. The dilemma of T1 esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2017 May;153(5):1206-1207. doi: 10.1016/j.jtcvs.2016.10.106. Epub 2017 Feb 16. [PMID: 28314532]
Sihag S, De La Torre S, Hsu M, Nobel T, Tan KS, Gerdes H, Shah P, Bains M, Jones DR, Molena D. Defining low-risk lesions in early-stage esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2020 Nov 24:S0022-5223(20)33097-X. doi: 10.1016/j.jtcvs.2020.10.138. Online ahead of print. [PMID: 33334599]
Sihag S, Ku GY, Tan KS, Nussenzweig S, Wu A, Janjigian YY, Jones DR, Molena D. Safety and feasibility of esophagectomy following combined immunotherapy and chemoradiotherapy for esophageal cancer. J Thorac Cardiovasc Surg. 2021 Mar;161(3):836-843.e1. doi: 10.1016/j.jtcvs.2020.11.106. Epub 2020 Dec 17. [PMID: 33485662]
Sihag S, Nobel T, Hsu M, Tan KS, Carr R, Janjigian YY, Tang LH, Wu AJ, Bott MJ, Isbell JM, Bains MS, Jones DR, Molena D. A More Extensive Lymphadenectomy Enhances Survival Following Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Adenocarcinoma. Ann Surg. 2020 Nov 12:10.1097/SLA.0000000000004479. doi: 10.1097/SLA.0000000000004479. Online ahead of print. [PMID: 33201124]
Visit PubMed for a full listing of Dr. Molena’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Daniela Molena discloses the following relationships and financial interests:
-
AstraZeneca
Provision of Services -
Bristol-Myers Squibb
Provision of Services
-
Johnson & Johnson
Provision of Services -
Merck & Co Inc.
Provision of Services
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].